0001127602-23-021003.txt : 20230719
0001127602-23-021003.hdr.sgml : 20230719
20230719161629
ACCESSION NUMBER: 0001127602-23-021003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitrano Richard J.
CENTRAL INDEX KEY: 0001785287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 231096906
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Frequency Therapeutics, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-315-4600
MAIL ADDRESS:
STREET 1: 75 HAYDEN AVENUE
STREET 2: SUITE 300
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-07-17
0001703647
Frequency Therapeutics, Inc.
FREQ
0001785287
Mitrano Richard J.
C/O FREQUENCY THERAPEUTICS, INC.,
75 HAYDEN AVE, SUITE 300
LEXINGTON
MA
02421
1
VP Finance & Operations
1
Common Stock
2023-07-17
4
S
0
244
.65
D
54264
D
Common Stock
2023-07-18
4
S
0
249
.56
D
54015
D
Common Stock
4032
I
The Carey/Mitrano Family Trust
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.62 to $0.66. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ James Abely, Attorney-in-Fact for Richard Mitrano
2023-07-19